Condition

Tuberous Sclerosis Complex (TSC)

ClinicalTrials.gov condition label

Clinical trials10

Recruiting5

Common interventions12

Lead sponsors shown9

Clinical trials

10 shown

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)NCT07287202 · 2026-07-14

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)NCT07575347 · 2026-05-04

Sapu003 in Advanced mTOR-sensitive Solid TumorsNCT07369505 · 2025-12-15

Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)NCT07403266 · 2024-06-01

Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous SclerosisNCT06764602 · 2021-07-01

TANDem-2: Closing the Gap to Interventions for TANDNCT06879665 · 2025-07-15

ENROLLING_BY_INVITATION

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.NCT06975605 · 2025-05-20

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy AdultsNCT06965881 · 2025-05-08

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)NCT00790400 · 2009-04-01

Precision Medicine for Neurocutaneous Syndromes in Western ChinaNCT07327164 · 2000-01-01

Common interventions

Everolimus (RAD001)DRUG1 Everolimus PlaceboDRUG1 Exemestane 25 MGDRUG1 Observational assessmentOTHER1 PlaceboDRUG1 Radiprodil + co-administered drugsDRUG1 Radiprodil with CarbamazepineDRUG1 Radiprodil with ItraconazoleDRUG1 Sapu003DRUG1 SVG103DRUG1 Well-Beans for Caregivers ProgramBEHAVIORAL1 YCJ-01 Full Spectrum cannbis ExtractDRUG1

Leading sponsors

GRIN Therapeutics, Inc.2 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 Novartis Pharmaceuticals1 Oils4Cure1 SAPU NANO (US) LLC1 Sovargen1 Stefan Lujinschi1 Vrije Universiteit Brussel1 West China Hospital1

Trial status mix

RECRUITING5

COMPLETED3

ENROLLING_BY_INVITATION1

TERMINATED1

Phase mix

PHASE14

PHASE32

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.